EP2853235A1 - Flipping-type graft fixation device with low flipping distance - Google Patents
Flipping-type graft fixation device with low flipping distance Download PDFInfo
- Publication number
- EP2853235A1 EP2853235A1 EP14186859.6A EP14186859A EP2853235A1 EP 2853235 A1 EP2853235 A1 EP 2853235A1 EP 14186859 A EP14186859 A EP 14186859A EP 2853235 A1 EP2853235 A1 EP 2853235A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- graft
- loop
- slot
- line
- retention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000014759 maintenance of location Effects 0.000 claims abstract description 50
- 239000000463 material Substances 0.000 claims description 5
- 239000013013 elastic material Substances 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 description 16
- 238000000034 method Methods 0.000 description 11
- 210000000689 upper leg Anatomy 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 230000008439 repair process Effects 0.000 description 7
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 6
- 238000002513 implantation Methods 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 3
- 230000004075 alteration Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 description 2
- 239000004792 Prolene Substances 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000000526 facies patellaris femoris Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0817—Structure of the anchor
- A61F2002/0823—Modular anchors comprising a plurality of separate parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0847—Mode of fixation of anchor to tendon or ligament
- A61F2002/0852—Fixation of a loop or U-turn, e.g. eyelets, anchor having multiple holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
- A61F2/0811—Fixation devices for tendons or ligaments
- A61F2002/0876—Position of anchor in respect to the bone
- A61F2002/0882—Anchor in or on top of a bone tunnel, i.e. a hole running through the entire bone
Definitions
- This application relates to graft fixation, and more particularly to graft tissue fixation employing flipping-type fixation devices.
- Flipping-type fixation devices such as disclosed in U.S. Patent Nos. 5,306,301 and 5,645,588 which are incorporated herein by reference, allow a simple procedure to be used for fixing tissue such as in an Anterior Cruciate Ligament (ACL) reconstruction.
- ACL Anterior Cruciate Ligament
- Such device comprises an elongated bar having a central suture loop depending therefrom.
- a tunnel is prepared in the femur from a position at or near the patellar surface up through a portion of the femur and exiting through the side of the femur at a superior location.
- a graft is looped over the loop attached to the elongated bar. The bar is able to pass in one direction up through the tunnel.
- the bar After exiting the superior end of the tunnel, the bar is flipped approximately 90 degrees so that it will not pass back through the tunnel and is positioned against the femur with the loop and graft hanging down into the tunnel therefrom. Tension on the graft keeps the bar in place against the bone surface.
- the bar To initiate the flipping, however, the bar must be passed completely outside of the tunnel. When it is then placed down against the bone the suture loop falls back into the tunnel by the amount that it was pulled free of the tunnel, about 50% of the length of the bar. This decreases the contact of the graft with the bone in the tunnel. Also, longer loop lengths have the potential to increase motion of the graft within the tunnel, thus potentially slowing the healing process in which the graft attaches to the bone.
- U.S. Patent Publication No. 20130204366 incorporated herein by reference, provides a bar in which the graft retention loop is able to move axially along the bar thereby reducing the distance the graft is pulled out of the tunnel during the flipping procedure.
- a graft retention device comprises an elongated body having a first end and a second end, a midpoint therebetween, and an upper surface and a lower surface.
- a first elongated slot and a second elongated slot through the body from the upper surface to the lower surface define tang therebetween.
- At least one of the first and second slots have an open first end into the body at the body first end such that the first end is closed via a retention line between the tang and the body.
- a graft retention loop disposed over the tang is slidable therealong from a first position closer to the body first end and a second position closer to the midpoint.
- each of the first slot and second slot has an open first end and each has a separate retention line or a single retention line which encloses both the first slot and the second slot.
- At least a portion of the retention line extends longitudinally beyond the first end of the body.
- the retention line comprises a flexible material.
- the retention line can comprise an elastic material.
- the retention line can comprise a metal wire.
- a leading line connects to the body at the second end.
- the tang slopes downwardly away from the first end.
- the graft retention device is provided in a sterile condition.
- the second position is located near the midpoint such as within a central 25% of a length of the elongated body between its first end and its second end.
- a trailing line connects to the body adjacent the slots and extends therefrom, when the graft retention loop is in the first position, through the graft retention loop toward the first end such that tension applied to the trailing line will thus tend to urge the graft retention loop away from the first position and toward the second position.
- a method according to the present invention provides for fixing a graft ligament into a bone tunnel.
- the method comprises the steps of: a) forming a graft construct by disposing the graft ligament over a loop slidably disposed upon a tang formed between two elongated slots of an elongated fixation buckle, the loop being slidable along the tang from a first position nearer a first end of the buckle to a second position nearer a midpoint of the buckle; b) pulling the graft construct up through the bone tunnel with a second end of the buckle leading and the loop in the first position; c) retaining the loop in the slots and on the tang in the first position via a retention line between the tang and a body forming the buckle at the first end of the buckle; and d) after the buckle has been pulled through the tunnel, reorienting the buckle to be crosswise to the tunnel on the bone adjacent the tunnel with the loop depending into the tunnel from the second position on the buckle.
- a portion of the retention line extends longitudinally beyond the first end of the buckle body when the loop is in the first position.
- the graft is moved no further upwards during the performance of step c) from its final position after step d) than 3.5mm. More preferably, the graft is moved no further upwards during the performance of step c) than its final position after step d).
- the bone tunnel comprises a lower graft channel and an upper passing channel, with the graft channel having a width exceeding a maximum width of the passing channel thereby forming an end surface of the graft channel where it meets the passing channel and wherein the method further comprises the step of holding the graft in compression against the end surface of the graft channel after step d).
- FIGS. 1 and 2 show a graft fixation device 10 according to the present invention. It comprises an elongated bar or buckle 12 having a graft receiving loop 14 depending therefrom.
- the buckle 12 comprises a first end 16 and second end 18, and an upper surface 20 and lower surface 22.
- the terms “upper” and “lower” and related terms such as “upwards” are used herein with reference to the surfaces of the buckle 12 just defined, with the lower surface 22 being that surface which will face a bone (not shown in FIG. 1 ) when the buckle 12 is employed.)
- a pair of longitudinal slots 32 penetrates the buckle 12 from the upper surface 20 to the lower surface 22 and extends from a first end 34 adjacent the buckle first end 16 to a second end 36 at a midpoint 38 of the buckle 12.
- the slots 32 define a retention tang 40 therebetween.
- An upper surface 42 of the retention tang slopes downwardly from the first end 34 of the slots 32 to the second end 36 to encourage the loop 14 to migrate toward the midpoint 38 at implantation.
- the loop 14 is received through the slots 32 and slides along the retention tang upper surface 42.
- a first hole 24 penetrates the tang 40 laterally adjacent the first end 16 and a second hole 26 penetrates the buckle 12 at the second end 18, passing from the upper surface 20 to the lower surface 22.
- the first hole 24 receives a trailing line 28 and the second hole 26 a leading line 30 for guiding the buckle 12 during implantation.
- the loop 14 when the loop 14 is toward the first end 34 it overlaps the first hole 24.
- the trailing line 28 is tightened upwardly during the flipping portion of implantation it will tend to push the loop 14 away from the first end 34.
- Placement of the hole 24 inboard of the first end 34 also allows the first end 34 of the slots 32 to be closer to the first end 16 of the buckle 12 and thereby reduce the flipping distance.
- the trailing line 28 and leading line 30 are preferably formed of ORTHOCORD #2 suture available from Ethicon, Inc. of Somerville, NJ.
- the leading line 30 may experience higher stress than the trailing line 28 while placing the fixation device 10 as will become apparent as the placement procedure is described.
- the second hole 26 is shown slightly larger than the first hole 24 (although they could be made the same size) and the leading line 30 can be a higher strength suture such as with a larger diameter than the trailing line 28. This difference can be used to differentiate the leading line 30 and trailing line 28. They can also be differentiated in some other fashion such as via varying colors or visual patterns.
- the vertical dimension of the retention tang 40 remains constant from the first end 34 to second end 36 to enhance its strength and rigidity, with the retention tang 40 thus depending slightly below the buckle lower surface 22 at the midpoint 38.
- the tang 40 is shown with a slope below the upper surface 20 of 13.6 degrees but could be anywhere from zero to about 45 degrees. It could also vary in slope, such as getting progressively steeper toward the midpoint 38 to encourage the loop to stay at the midpoint 38 after implantation.
- the buckle 12 is approximately 12 mm long, 4 mm wide and 1.5 to 2.5 mm thick, with the thickest portion being the midpoint 38 where the tang 40 depends.
- the tang 40 is approximately 1.5 mm thick.
- the buckle 12 is preferably formed of a biocompatible material such as 6Al-4V Ti alloy.
- the loop 14 is woven of ultra-high molecular weight polyethylene, such as DYNEEMA, and polyester.
- the material of the loop 14 is preferably about 2 mm in diameter, preferably being in a range of from #2-0 up through about 4 mm, and the loop 14 is preferably between about 8 mm and 60 mm long.
- the loop 14 can be woven onto the buckle 12 to form a continuous loop without knots.
- U.S. Patent No. 6,352,603 to Bryant incorporated herein by reference, illustrates one method for achieving such a construct.
- a graft construct 44 comprises a tissue graft 46 looped over the loop 14 of the fixation device 10 and is show in place in a patient's leg 48.
- a tunnel 50 in the leg's femur 52 comprises a larger diameter inferior portion or socket 54 sized to accommodate the graft 46 and a smaller diameter superior portion or passing channel 56 sized to accept the buckle 12 in a lengthwise orientation.
- the buckle 12 sits against the femur 52 in a sideways orientation with the loop 14 depending down through the passing channel 56 and into the socket 54 in which is placed the graft 46.
- An opposite end of the graft 46 is placed into a tibial tunnel 58 in the leg's tibia 60 and held in place with an anchor 62 such as the INTRAFIX® anchor available from DePuy Mitek Inc. of Raynham, MA.
- an anchor 62 such as the INTRAFIX® anchor available from DePuy Mitek Inc. of Raynham, MA.
- FIGS. 4A to 4D the process of passing the buckle 12 up through the tunnel 50 and especially the passing channel 56 will be described.
- the graft tissue 46 is threaded through the loop 14.
- a longitudinal axis 60 of the buckle 12 is oriented coaxially with a longitudinal axis 62 of the tunnel 50, with the loop 14 depending from the first end 34 of the slots 32 ( FIG. 4A ).
- Tension on the leading line 30 pulls the second end 18 of the buckle 12 upwardly out of the passing channel 56 until the first end 16 is free of the passing channel 56 ( FIG. 4B ).
- the loop 14 and the passing channel 56 are dimensioned so that if the graft construct 44 is pulled up until the graft tissue 46 abuts an end 55 of the socket 54 the first end 16 of the buckle 12 has just cleared the end of the passing channel 56 thus providing tactile feedback to the surgeon that the buckle 12 is properly positioned to be rotated.
- the graft 46 shown in FIGS. 4A to 4D is not to scale and is shown as a thin line so as to better illustrate the construction of the socket 54. In reality the graft 46 would be fatter such that it entirely fills the width of the socket 54. Contact between the graft 46 and the bone forming the socket 54 allows the graft to grow into and merge with the bone to form a permanent repair.
- Rotation is approximately 90 degrees and can occur by applying tension to the trailing line 28 ( FIG. 4C ).
- the final orientation depends upon the angle at which the tunnel 50 penetrates the femur 52.
- opposing tension supplied by the graft tissue 46 tends to cause the loop 14 to slide along the retention tang 40 leaving it depending down into the passing channel 56 from the midpoint 38 of the buckle 12. This occurs with a distinct snapping motion that can be felt by the surgeon through the trailing line 28 to provide tactile feedback that the migration has occurred properly.
- the trailing line 28 and leading line 30 are then removed and tension from the graft tissue 46 pulls the buckle 12 lower surface 22 firmly against the femur 52 ( FIG. 4D ).
- the crosswise orientation of the buckle 12 versus the passing channel 56 and the loop 14 depending from the midpoint 38 of the buckle 12 prevent the buckle from migrating back into the passing channel 56 thus providing secure fixation of the graft tissue 46.
- the slope of the tang upper surface 42 assists in urging the loop 14 toward the midpoint 38. Its angle on the femur 52 versus the tunnel 50 also tends to pull the loop 14 across the buckle 12 to sit at the slot second ends 36 and the buckle 12. Locating the ends 36 at the midpoint 38 thus helps keep the loop 14 seated at the midpoint 38.
- the term "midpoint" can be broadly construed. Seating at the exact middle of the buckle 12 provides an equal amount of buckle to each side thereof to minimize any chance that the buckle 12 can slip along the bone in such a fashion that and end thereof could fall back into the passing channel 56. In practical terms the loop 14 can be seated in other locations yet still be safely situated to prevent the buckle 12 from falling back into the passing channel 56.
- the loop 14 is seated somewhere in the middle 50% of the length of the buckle 12 and more preferably within the middle 25%.
- the flipping distance is representative of the gap between the graft 46 and the end of the socket 54. Ideally this gap is zero and the graft 46 extends all the way to the end of the socket 54.
- FIG. 5 illustrates a further embodiment of a buckle 100 according to the present invention. It comprises a body 102 having first and second ends 104 and 106 with holes 108 and 110 for trailing and leading lines 107 and 109 respectively. It also has slots 112 forming a tang 114 for supporting a graft support loop 115. The slots 112 extend from a midpoint 116 to the first end 104 rather than being enclosed by the body 102 at the first end 104 as in the previous embodiment. To retain the loop on the tang 114 a retaining line 118 is provided through aperture 120 in the tang 114 and adjacent apertures 122 in the body 102.
- the retaining line 118 can be a suture, wire or other material with sufficient tensile strength to retain the loop. It can be flexible, stretchable or rigid. As shown in FIG. 5 it bows outwardly 124 between the tang 114 and adjacent body 102 to further minimize the flipping distance, but it could be made straight with no bowing.
- the bowing 124 can be present in a resting state such as being formed in a wire, or may by dynamically formed under force of the loop 115 against the retaining line 118 if the line 118 is formed of an elastic material which stretches to form the bowing 124.
- the line 118 could be formed of a suture with a lower than average modulus of elasticity such as PDS (Polydioxanone) or Prolene and multiple lengths of such suture could be employed to form the line 118 with sufficient strength. Rubber or silicone materials, as for instance silicone tubing, of an implantable grade could are other possibilities for an elastic material.
- the bowing 124 could be formed by the line 118 being flexible, such as a suture, with sufficient slack as to form the bowing 124 especially when the loop presses against it.
- Fixation of the line 118 in the apertures 122 can be effected by providing knots 126 the ends of the line 118, particularly if it is formed of suture, such that the knots 126 cannot pass through the apertures 122.
- Other methods for fixation include welding, adhesives, interference screws etc.
- the buckle 100 could have a flipping distance of zero or even a negative value allowing the graft to be seated to the end 55 of the graft socket 54 (not shown in FIG. 5 ). With sufficient bowing 124 and a negative flipping distance, the graft will reach the end 55 of the graft socket 54 as the buckle 100 is flipped. After the flipping is completed and the buckle 100 is seated against the bone the loop 115 would be pulled upwards versus its position during flipping such that a tension in the loop 115 would pull the graft into contact with the end 55 of the socket 54 with a contact force thereagainst thereby maximizing the bone to graft contact area of the completed repair. In prior devices this bone surface 55 is wasted as they do not allow the graft to contact it sufficient to achieve ingrowth between the graft and the bone.
- the loop 115 is preferably a continuous closed loop. Formation of such a structure through weaving etc. is made more difficult if it must be formed around the tang 114. With the design of FIG. 5 the loop 115 can be formed alone which is much easier and then slipped onto the tang 114 prior to placing the line 118 onto the buckle 100. This simplifies manufacturing.
- Refinements and variations to the buckle could include slots which extend to both sides such that the second side mirrors the first, and the retention tang sloping down from both ends toward the center. This would allow a surgeon to pull the buckle up through the tunnel 50 by either end. Also, the upper surface of the retention tang could be rounded to provide a better surface for the loop 14 to ride over and lessen chafing of the loop 14.
- the tang can have a pronounced dip to capture and retain the loop 14 at the midpoint.
- the buckle is particularly suited to ACL repair, but can be useful in other repairs such as for example reattachment of a biceps brachii tendon.
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application relates to graft fixation, and more particularly to graft tissue fixation employing flipping-type fixation devices.
- Flipping-type fixation devices, such as disclosed in
U.S. Patent Nos. 5,306,301 and5,645,588 which are incorporated herein by reference, allow a simple procedure to be used for fixing tissue such as in an Anterior Cruciate Ligament (ACL) reconstruction. Such device comprises an elongated bar having a central suture loop depending therefrom. A tunnel is prepared in the femur from a position at or near the patellar surface up through a portion of the femur and exiting through the side of the femur at a superior location. A graft is looped over the loop attached to the elongated bar. The bar is able to pass in one direction up through the tunnel. After exiting the superior end of the tunnel, the bar is flipped approximately 90 degrees so that it will not pass back through the tunnel and is positioned against the femur with the loop and graft hanging down into the tunnel therefrom. Tension on the graft keeps the bar in place against the bone surface. - To initiate the flipping, however, the bar must be passed completely outside of the tunnel. When it is then placed down against the bone the suture loop falls back into the tunnel by the amount that it was pulled free of the tunnel, about 50% of the length of the bar. This decreases the contact of the graft with the bone in the tunnel. Also, longer loop lengths have the potential to increase motion of the graft within the tunnel, thus potentially slowing the healing process in which the graft attaches to the bone.
-
U.S. Patent Publication No. 20130204366 , incorporated herein by reference, provides a bar in which the graft retention loop is able to move axially along the bar thereby reducing the distance the graft is pulled out of the tunnel during the flipping procedure. - A graft retention device according to the present invention comprises an elongated body having a first end and a second end, a midpoint therebetween, and an upper surface and a lower surface. A first elongated slot and a second elongated slot through the body from the upper surface to the lower surface define tang therebetween. At least one of the first and second slots have an open first end into the body at the body first end such that the first end is closed via a retention line between the tang and the body. A graft retention loop disposed over the tang is slidable therealong from a first position closer to the body first end and a second position closer to the midpoint.
- Preferably, each of the first slot and second slot has an open first end and each has a separate retention line or a single retention line which encloses both the first slot and the second slot.
- Preferably, at least a portion of the retention line extends longitudinally beyond the first end of the body.
- In one aspect of the invention, the retention line comprises a flexible material. The retention line can comprise an elastic material. The retention line can comprise a metal wire.
- Preferably, a leading line connects to the body at the second end.
- Preferably, the tang slopes downwardly away from the first end.
- Preferably, the graft retention device is provided in a sterile condition.
- Preferably, the second position is located near the midpoint such as within a central 25% of a length of the elongated body between its first end and its second end.
- In one aspect of the invention, a trailing line connects to the body adjacent the slots and extends therefrom, when the graft retention loop is in the first position, through the graft retention loop toward the first end such that tension applied to the trailing line will thus tend to urge the graft retention loop away from the first position and toward the second position.
- A method according to the present invention provides for fixing a graft ligament into a bone tunnel. The method comprises the steps of: a) forming a graft construct by disposing the graft ligament over a loop slidably disposed upon a tang formed between two elongated slots of an elongated fixation buckle, the loop being slidable along the tang from a first position nearer a first end of the buckle to a second position nearer a midpoint of the buckle; b) pulling the graft construct up through the bone tunnel with a second end of the buckle leading and the loop in the first position; c) retaining the loop in the slots and on the tang in the first position via a retention line between the tang and a body forming the buckle at the first end of the buckle; and d) after the buckle has been pulled through the tunnel, reorienting the buckle to be crosswise to the tunnel on the bone adjacent the tunnel with the loop depending into the tunnel from the second position on the buckle.
- Preferably, a portion of the retention line extends longitudinally beyond the first end of the buckle body when the loop is in the first position. Preferably, the graft is moved no further upwards during the performance of step c) from its final position after step d) than 3.5mm. More preferably, the graft is moved no further upwards during the performance of step c) than its final position after step d). Most preferably, the bone tunnel comprises a lower graft channel and an upper passing channel, with the graft channel having a width exceeding a maximum width of the passing channel thereby forming an end surface of the graft channel where it meets the passing channel and wherein the method further comprises the step of holding the graft in compression against the end surface of the graft channel after step d).
-
-
FIG. 1 is a perspective view of a fixation device buckle according to the present invention; -
FIG. 2 is a sectional view taken along line 2-2 ofFIG. 1 ; -
FIG. 3 is a side elevation view in cross-section of a ACL repair in a knee employing the fixation device ofFIG. 1 ; -
FIGS. 4A to 4D are side elevation views in cross-section of an ACL repair procedure employing the fixation device ofFIG. 1 ; and -
FIG. 5 is a top perspective view of an alternative embodiment of a buckle according to the present invention. -
FIGS. 1 and2 show agraft fixation device 10 according to the present invention. It comprises an elongated bar orbuckle 12 having agraft receiving loop 14 depending therefrom. Thebuckle 12 comprises afirst end 16 andsecond end 18, and anupper surface 20 andlower surface 22. The terms "upper" and "lower" and related terms such as "upwards" are used herein with reference to the surfaces of thebuckle 12 just defined, with thelower surface 22 being that surface which will face a bone (not shown inFIG. 1 ) when thebuckle 12 is employed.) - A pair of
longitudinal slots 32 penetrates thebuckle 12 from theupper surface 20 to thelower surface 22 and extends from afirst end 34 adjacent the bucklefirst end 16 to asecond end 36 at amidpoint 38 of thebuckle 12. Theslots 32 define aretention tang 40 therebetween. Anupper surface 42 of the retention tang slopes downwardly from thefirst end 34 of theslots 32 to thesecond end 36 to encourage theloop 14 to migrate toward themidpoint 38 at implantation. Theloop 14 is received through theslots 32 and slides along the retention tangupper surface 42. - A
first hole 24 penetrates thetang 40 laterally adjacent thefirst end 16 and asecond hole 26 penetrates thebuckle 12 at thesecond end 18, passing from theupper surface 20 to thelower surface 22. Thefirst hole 24 receives atrailing line 28 and the second hole 26 a leadingline 30 for guiding thebuckle 12 during implantation. As best seen inFIG. 2 , when theloop 14 is toward thefirst end 34 it overlaps thefirst hole 24. When thetrailing line 28 is tightened upwardly during the flipping portion of implantation it will tend to push theloop 14 away from thefirst end 34. Placement of thehole 24 inboard of thefirst end 34 also allows thefirst end 34 of theslots 32 to be closer to thefirst end 16 of thebuckle 12 and thereby reduce the flipping distance. - The
trailing line 28 and leadingline 30 are preferably formed of ORTHOCORD #2 suture available from Ethicon, Inc. of Somerville, NJ. The leadingline 30 may experience higher stress than thetrailing line 28 while placing thefixation device 10 as will become apparent as the placement procedure is described. Thesecond hole 26 is shown slightly larger than the first hole 24 (although they could be made the same size) and the leadingline 30 can be a higher strength suture such as with a larger diameter than thetrailing line 28. This difference can be used to differentiate the leadingline 30 andtrailing line 28. They can also be differentiated in some other fashion such as via varying colors or visual patterns. - Preferably, the vertical dimension of the
retention tang 40 remains constant from thefirst end 34 tosecond end 36 to enhance its strength and rigidity, with theretention tang 40 thus depending slightly below the bucklelower surface 22 at themidpoint 38. Thetang 40 is shown with a slope below theupper surface 20 of 13.6 degrees but could be anywhere from zero to about 45 degrees. It could also vary in slope, such as getting progressively steeper toward themidpoint 38 to encourage the loop to stay at themidpoint 38 after implantation. - Preferably, for an ACL repair the
buckle 12 is approximately 12 mm long, 4 mm wide and 1.5 to 2.5 mm thick, with the thickest portion being themidpoint 38 where thetang 40 depends. Thetang 40 is approximately 1.5 mm thick. Thebuckle 12 is preferably formed of a biocompatible material such as 6Al-4V Ti alloy. Preferably, theloop 14 is woven of ultra-high molecular weight polyethylene, such as DYNEEMA, and polyester. The material of theloop 14 is preferably about 2 mm in diameter, preferably being in a range of from #2-0 up through about 4 mm, and theloop 14 is preferably between about 8 mm and 60 mm long. Theloop 14 can be woven onto thebuckle 12 to form a continuous loop without knots.U.S. Patent No. 6,352,603 to Bryant , incorporated herein by reference, illustrates one method for achieving such a construct. - Turning also now to
FIG. 3 , agraft construct 44 comprises atissue graft 46 looped over theloop 14 of thefixation device 10 and is show in place in a patient'sleg 48. Atunnel 50 in the leg'sfemur 52 comprises a larger diameter inferior portion orsocket 54 sized to accommodate thegraft 46 and a smaller diameter superior portion or passingchannel 56 sized to accept thebuckle 12 in a lengthwise orientation. Thebuckle 12 sits against thefemur 52 in a sideways orientation with theloop 14 depending down through the passingchannel 56 and into thesocket 54 in which is placed thegraft 46. An opposite end of thegraft 46 is placed into atibial tunnel 58 in the leg'stibia 60 and held in place with ananchor 62 such as the INTRAFIX® anchor available from DePuy Mitek Inc. of Raynham, MA. - Turning also now to
FIGS. 4A to 4D the process of passing thebuckle 12 up through thetunnel 50 and especially the passingchannel 56 will be described. At the start of the procedure, thegraft tissue 46 is threaded through theloop 14. Alongitudinal axis 60 of thebuckle 12 is oriented coaxially with alongitudinal axis 62 of thetunnel 50, with theloop 14 depending from thefirst end 34 of the slots 32 (FIG. 4A ). Tension on the leadingline 30 pulls thesecond end 18 of thebuckle 12 upwardly out of the passingchannel 56 until thefirst end 16 is free of the passing channel 56 (FIG. 4B ). Preferably, theloop 14 and the passingchannel 56 are dimensioned so that if the graft construct 44 is pulled up until thegraft tissue 46 abuts anend 55 of thesocket 54 thefirst end 16 of thebuckle 12 has just cleared the end of the passingchannel 56 thus providing tactile feedback to the surgeon that thebuckle 12 is properly positioned to be rotated. Thegraft 46 shown inFIGS. 4A to 4D is not to scale and is shown as a thin line so as to better illustrate the construction of thesocket 54. In reality thegraft 46 would be fatter such that it entirely fills the width of thesocket 54. Contact between thegraft 46 and the bone forming thesocket 54 allows the graft to grow into and merge with the bone to form a permanent repair. - Rotation is approximately 90 degrees and can occur by applying tension to the trailing line 28 (
FIG. 4C ). The final orientation depends upon the angle at which thetunnel 50 penetrates thefemur 52. As thebuckle 12 is rotated, opposing tension supplied by thegraft tissue 46 tends to cause theloop 14 to slide along theretention tang 40 leaving it depending down into the passingchannel 56 from themidpoint 38 of thebuckle 12. This occurs with a distinct snapping motion that can be felt by the surgeon through the trailingline 28 to provide tactile feedback that the migration has occurred properly. The trailingline 28 and leadingline 30 are then removed and tension from thegraft tissue 46 pulls thebuckle 12lower surface 22 firmly against the femur 52 (FIG. 4D ). The crosswise orientation of thebuckle 12 versus the passingchannel 56 and theloop 14 depending from themidpoint 38 of thebuckle 12 prevent the buckle from migrating back into the passingchannel 56 thus providing secure fixation of thegraft tissue 46. - The slope of the tang
upper surface 42 assists in urging theloop 14 toward themidpoint 38. Its angle on thefemur 52 versus thetunnel 50 also tends to pull theloop 14 across thebuckle 12 to sit at the slot second ends 36 and thebuckle 12. Locating theends 36 at themidpoint 38 thus helps keep theloop 14 seated at themidpoint 38. In terms of final seating of theloop 14 the term "midpoint" can be broadly construed. Seating at the exact middle of thebuckle 12 provides an equal amount of buckle to each side thereof to minimize any chance that thebuckle 12 can slip along the bone in such a fashion that and end thereof could fall back into the passingchannel 56. In practical terms theloop 14 can be seated in other locations yet still be safely situated to prevent thebuckle 12 from falling back into the passingchannel 56. Preferably, theloop 14 is seated somewhere in the middle 50% of the length of thebuckle 12 and more preferably within the middle 25%. - The flipping distance is representative of the gap between the
graft 46 and the end of thesocket 54. Ideally this gap is zero and thegraft 46 extends all the way to the end of thesocket 54. -
FIG. 5 illustrates a further embodiment of abuckle 100 according to the present invention. It comprises abody 102 having first and second ends 104 and 106 withholes lines slots 112 forming atang 114 for supporting agraft support loop 115. Theslots 112 extend from amidpoint 116 to thefirst end 104 rather than being enclosed by thebody 102 at thefirst end 104 as in the previous embodiment. To retain the loop on the tang 114 aretaining line 118 is provided throughaperture 120 in thetang 114 andadjacent apertures 122 in thebody 102. - The retaining
line 118 can be a suture, wire or other material with sufficient tensile strength to retain the loop. It can be flexible, stretchable or rigid. As shown inFIG. 5 it bows outwardly 124 between thetang 114 andadjacent body 102 to further minimize the flipping distance, but it could be made straight with no bowing. The bowing 124 can be present in a resting state such as being formed in a wire, or may by dynamically formed under force of theloop 115 against the retainingline 118 if theline 118 is formed of an elastic material which stretches to form the bowing 124. For instance theline 118 could be formed of a suture with a lower than average modulus of elasticity such as PDS (Polydioxanone) or Prolene and multiple lengths of such suture could be employed to form theline 118 with sufficient strength. Rubber or silicone materials, as for instance silicone tubing, of an implantable grade could are other possibilities for an elastic material. The bowing 124 could be formed by theline 118 being flexible, such as a suture, with sufficient slack as to form the bowing 124 especially when the loop presses against it. - Fixation of the
line 118 in theapertures 122 can be effected by providingknots 126 the ends of theline 118, particularly if it is formed of suture, such that theknots 126 cannot pass through theapertures 122. Other methods for fixation include welding, adhesives, interference screws etc. - With sufficient bowing 124 the
buckle 100 could have a flipping distance of zero or even a negative value allowing the graft to be seated to theend 55 of the graft socket 54 (not shown inFIG. 5 ). Withsufficient bowing 124 and a negative flipping distance, the graft will reach theend 55 of thegraft socket 54 as thebuckle 100 is flipped. After the flipping is completed and thebuckle 100 is seated against the bone theloop 115 would be pulled upwards versus its position during flipping such that a tension in theloop 115 would pull the graft into contact with theend 55 of thesocket 54 with a contact force thereagainst thereby maximizing the bone to graft contact area of the completed repair. In prior devices thisbone surface 55 is wasted as they do not allow the graft to contact it sufficient to achieve ingrowth between the graft and the bone. - The
loop 115 is preferably a continuous closed loop. Formation of such a structure through weaving etc. is made more difficult if it must be formed around thetang 114. With the design ofFIG. 5 theloop 115 can be formed alone which is much easier and then slipped onto thetang 114 prior to placing theline 118 onto thebuckle 100. This simplifies manufacturing. - Refinements and variations to the buckle could include slots which extend to both sides such that the second side mirrors the first, and the retention tang sloping down from both ends toward the center. This would allow a surgeon to pull the buckle up through the
tunnel 50 by either end. Also, the upper surface of the retention tang could be rounded to provide a better surface for theloop 14 to ride over and lessen chafing of theloop 14. - Provision can be made to discourage the
loop 14 from moving away from themidpoint 38, such as by providing barbs (not shown) along theupper surface 42 or other areas of thebuckle 12 where they may engage theloop 14 as it slides along theslots 32. The tang can have a pronounced dip to capture and retain theloop 14 at the midpoint. - The buckle is particularly suited to ACL repair, but can be useful in other repairs such as for example reattachment of a biceps brachii tendon.
- The invention has been described with reference to the preferred embodiments. Obviously, modifications and alterations will occur to others upon reading and understanding the preceding detailed description. It is intended that the invention be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
Claims (12)
- A graft retention device comprising:an elongated body having a first end and a second end, a midpoint therebetween, and an upper surface and a lower surface;a first elongated slot and a second elongated slot through the body from the upper surface to the lower surface, defining a tang therebetween;at least one of the first slot and the second slot having an open slot first end into the body at the body first end, such open slot first end being closed via a retention line between the tang and the body; anda graft retention loop disposed over the tang and slidable therealong from a first position closer to the body first end and a second position closer to the midpoint;
- A graft retention device according to claim 1 wherein each of the first slot and second slot has an open first end and each has a separate retention line.
- A graft retention device according to claim 1 each of the first slot and second slot has an open first end and wherein a single retention line encloses both the first slot and the second slot.
- A graft retention device according to any preceding claim wherein at least a portion of the retention line extends longitudinally beyond the first end of the body.
- A graft retention device according to any preceding claim wherein the retention line comprises a flexible material.
- A graft retention device according to any preceding claim wherein the retention line comprises an elastic material.
- A graft retention device according to any preceding claim wherein the retention line comprises a metal wire.
- A graft retention device according to any preceding claim and further comprising a leading line connected to the body at the second end.
- A graft retention device according to any preceding claim wherein the tang slopes downwardly away from the first end.
- A graft retention device according to any preceding claim which is sterile.
- A graft retention device according to any preceding claim wherein the second position is located within a central 25% of a length of the elongated body between its first end and its second end.
- A graft retention device according to any preceding claim and further comprising a trailing line connected to the body adjacent the slots and extending therefrom, when the graft retention loop is in the first position, through the graft retention loop toward the first end such that tension applied to the trailing line will thus tend to urge the graft retention loop away from the first position and toward the second position.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/041,764 US10813741B2 (en) | 2013-09-30 | 2013-09-30 | Flipping-type graft fixation device and method with low flipping distance |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2853235A1 true EP2853235A1 (en) | 2015-04-01 |
EP2853235B1 EP2853235B1 (en) | 2018-05-16 |
Family
ID=51628026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14186859.6A Active EP2853235B1 (en) | 2013-09-30 | 2014-09-29 | Flipping-type graft fixation device with low flipping distance |
Country Status (7)
Country | Link |
---|---|
US (2) | US10813741B2 (en) |
EP (1) | EP2853235B1 (en) |
JP (1) | JP6482806B2 (en) |
CN (1) | CN104510510B (en) |
AU (1) | AU2014233623B2 (en) |
CA (1) | CA2864553A1 (en) |
IN (1) | IN2014DE02613A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8834523B2 (en) * | 2011-09-29 | 2014-09-16 | Smith & Nephew, Inc. | Attachment device to attach tissue graft |
US9937032B2 (en) | 2015-06-04 | 2018-04-10 | Medos International Sarl | Tissue fixation device |
CN107028684B (en) * | 2017-05-12 | 2019-04-19 | 上海利格泰生物科技有限公司 | The direct Suspending fixation device of soft material tissue grafts |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306301A (en) | 1993-02-11 | 1994-04-26 | American Cyanamid Company | Graft attachment device and method of using same |
US6352603B1 (en) | 1998-03-13 | 2002-03-05 | Neoligaments Limited | Loop attachment to apertured device |
WO2007109665A1 (en) * | 2006-03-20 | 2007-09-27 | Smith & Nephew, Inc. | Tissue graft fixation |
WO2013049453A1 (en) * | 2011-09-29 | 2013-04-04 | Smith & Nephew, Inc. | Attachment device to attach tissue graft |
EP2623066A1 (en) * | 2012-02-02 | 2013-08-07 | DePuy Mitek, LLC | Flipping-type graft fixation device and method |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5632748A (en) * | 1993-06-14 | 1997-05-27 | Linvatec Corporation | Endosteal anchoring device for urging a ligament against a bone surface |
GB2288739A (en) | 1994-04-27 | 1995-11-01 | Corin Medical Ltd | Surgical anchor |
GB9620046D0 (en) * | 1996-09-26 | 1996-11-13 | Neoligaments | Attachment device for use in the implantation of prosthetic ligament |
JPH10127672A (en) | 1996-10-31 | 1998-05-19 | Shinichi Sawazaki | End button for fixing reconstructed ligament with ball-shaped cable crimp |
US5769894A (en) | 1997-02-05 | 1998-06-23 | Smith & Nephew, Inc. | Graft attachment device and method of attachment |
JPH11206793A (en) | 1998-01-29 | 1999-08-03 | Ikushi Yamada | Anchor for hanging ligament with slit |
US6086591A (en) | 1999-01-29 | 2000-07-11 | Smith & Nephew, Inc. | Soft tissue anchor |
DE19941574A1 (en) | 1999-09-01 | 2001-03-08 | Storz Karl Gmbh & Co Kg | Instruments for implanting a tendon replacement |
JP2002017741A (en) | 2000-07-03 | 2002-01-22 | Ikushi Yamada | Ligament hanging anchor |
US6533802B2 (en) | 2001-05-16 | 2003-03-18 | Smith & Nephew, Inc. | Endobutton continuous loop for bone-tendon-bone |
US7594923B2 (en) | 2003-06-11 | 2009-09-29 | Medicine Lodge, Inc | Line lock suture attachment systems and methods |
US7150757B2 (en) | 2003-06-11 | 2006-12-19 | Fallin T Wade | Adjustable line locks and methods |
US7806909B2 (en) | 2003-06-11 | 2010-10-05 | Medicine Lodge Inc. | Line lock threading systems and methods |
US8852250B2 (en) * | 2006-05-18 | 2014-10-07 | Linvatec Corporation | Graft fixation implant |
FR2926456A1 (en) | 2008-01-21 | 2009-07-24 | Fournitures Hospitalieres Ind | Ligament transplant fixing device for reconstructing e.g. posterior cruciate ligament, has insertion part impacted in tunnel that is formed in bone, where insertion part has passage hole through which transplant is passed |
GB0801956D0 (en) | 2008-02-02 | 2008-03-12 | Imp Innovations Ltd | Adjustable ligament graft fixation |
AU2009200864A1 (en) | 2008-02-29 | 2009-09-17 | Robert J. Medoff | Method and apparatus for articular scapholunate reconstruction |
AU2011227190B2 (en) | 2010-03-18 | 2016-04-14 | Smith & Nephew, Inc. | A device for use during ligament reconstruction surgery |
US8721683B2 (en) | 2011-09-29 | 2014-05-13 | Smith & Nephew, Inc. | Attachment device to attach tissue graft |
US20130116787A1 (en) | 2011-11-08 | 2013-05-09 | Smith & Nephew, Inc. | Adjustable graft attachment |
-
2013
- 2013-09-30 US US14/041,764 patent/US10813741B2/en active Active
-
2014
- 2014-09-11 IN IN2613DE2014 patent/IN2014DE02613A/en unknown
- 2014-09-22 CA CA 2864553 patent/CA2864553A1/en not_active Abandoned
- 2014-09-25 JP JP2014195294A patent/JP6482806B2/en active Active
- 2014-09-26 AU AU2014233623A patent/AU2014233623B2/en active Active
- 2014-09-28 CN CN201410510311.2A patent/CN104510510B/en active Active
- 2014-09-29 EP EP14186859.6A patent/EP2853235B1/en active Active
-
2020
- 2020-10-26 US US17/079,711 patent/US11717394B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306301A (en) | 1993-02-11 | 1994-04-26 | American Cyanamid Company | Graft attachment device and method of using same |
US5645588A (en) | 1993-02-11 | 1997-07-08 | Acufex Microsurgical, Inc. | Graft attachment device |
US6352603B1 (en) | 1998-03-13 | 2002-03-05 | Neoligaments Limited | Loop attachment to apertured device |
WO2007109665A1 (en) * | 2006-03-20 | 2007-09-27 | Smith & Nephew, Inc. | Tissue graft fixation |
WO2013049453A1 (en) * | 2011-09-29 | 2013-04-04 | Smith & Nephew, Inc. | Attachment device to attach tissue graft |
EP2623066A1 (en) * | 2012-02-02 | 2013-08-07 | DePuy Mitek, LLC | Flipping-type graft fixation device and method |
US20130204366A1 (en) | 2012-02-02 | 2013-08-08 | Depuy Mitek, Inc. | Flipping-type graft fixation device and method |
Also Published As
Publication number | Publication date |
---|---|
JP6482806B2 (en) | 2019-03-13 |
AU2014233623B2 (en) | 2018-08-16 |
CN104510510A (en) | 2015-04-15 |
US11717394B2 (en) | 2023-08-08 |
JP2015066441A (en) | 2015-04-13 |
CA2864553A1 (en) | 2015-03-30 |
US20210038365A1 (en) | 2021-02-11 |
US10813741B2 (en) | 2020-10-27 |
EP2853235B1 (en) | 2018-05-16 |
US20150094742A1 (en) | 2015-04-02 |
CN104510510B (en) | 2020-10-23 |
IN2014DE02613A (en) | 2015-06-26 |
AU2014233623A1 (en) | 2015-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10667901B2 (en) | Flipping-type graft fixation device and method with low flipping distance | |
US11717394B2 (en) | Flipping-type graft fixation device and method with low flipping distance | |
US10016269B2 (en) | Flipping-type graft fixation device and method | |
US20210169466A1 (en) | Implant having adjustable filament coils | |
US9486211B2 (en) | Method for implanting soft tissue | |
EP2832314B1 (en) | Adjustable graft fixation device | |
KR102369947B1 (en) | Bidirectional adjustable loop suspension device for immobilization of soft tissue grafts | |
EP2775959A1 (en) | Adjustable graft attachment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140929 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
R17P | Request for examination filed (corrected) |
Effective date: 20150930 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
17Q | First examination report despatched |
Effective date: 20161125 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20171128 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
INTC | Intention to grant announced (deleted) | ||
GRAR | Information related to intention to grant a patent recorded |
Free format text: ORIGINAL CODE: EPIDOSNIGR71 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
INTG | Intention to grant announced |
Effective date: 20180405 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM AND CO. AG PATENT- UND MARKENANWAELTE , CH |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014025468 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 998876 Country of ref document: AT Kind code of ref document: T Effective date: 20180615 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180516 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180816 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180816 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180817 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 998876 Country of ref document: AT Kind code of ref document: T Effective date: 20180516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014025468 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190219 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20180930 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140929 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180516 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180516 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180916 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20220811 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20231001 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240806 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240808 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240808 Year of fee payment: 11 |